Vibiosphen Is A French Biotech Company Founded In 2014Specializing In Infectious Diseases With A Focus On The One Health Paradigmthis Approach Integrates Humananimaland Environmental Health To Tackle Global Health Challengesparticularly Antimicrobial Resistanceas A Contract Research Organizationcro Vibiosphen Supports The Development Of Pharmaceutical Compounds Aimed At Treating Infectious Diseases The Company Offers A Variety Of Servicesincluding Preclinical Studies That Utilize Custom In Vitro And In Vivo Models To Test The Efficacy And Safety Of Potential Treatmentsvibiosphen Also Provides Drug Development Supporthelping Clients Design And Execute Preclinical Studiesadditionallythe Company Collaborates With Partners Like Pierre Fabre To Screen Plant Samples And Phytochemical Compounds For New Natural Molecules With Therapeutic Potential With A Small Team And Funding From Horizon Europevibiosphen Is Committed To Enhancing Drug Development Processes And Contributing To The Discovery Of Novel Antibioticsits Expertise In Microbiology Positions The Company To Effectively Support Clients In The Complex Landscape Of Infectious Disease Research
